POM-V Prescription Required

VIMCO Emulsion for Injection for Ewes and Female Goats

Active ingredient: Staphylococcus aureus

Form

Injection

Species

Goats Sheep

Manufacturer

Laboratorios Hipra SA

VMD MA No.

17533/5016

What it's used for

For active immunisation of healthy ewes in flocks with recurring mastitis problems, to reduce the incidence of sub-clinical mastitis (reduction of udder le...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Staphylococcus aureus

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

VIMCO Emulsion for Injection for Ewes and Female Goats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

For active immunisation of healthy ewes in flocks with recurring mastitis problems, to
reduce the incidence of sub-clinical mastitis (reduction of udder lesions, somatic cell
count and S. aureus count) caused by Staphylococcus aureus.
For active immunisation of healthy female goats
problems, to reduce the incidence of sub-clinical mastitis caused by
aureus
Coagulase-Negative Staphylococci* however occurs, the severity of clinical signs
(udder and milk aspect) is reduced.
(*Determination of the CNS species has not been performed)

Revised: September 2023
Divergence from NI MA following AN: 03684/2022Page 2 of 6The onset of immunity in ewes is 6 weeks.
The onset of immunity in goats has not been established (see section 5).
The duration of immunity in ewes and goats has not been established.

Intramuscular use.
Allow the vaccine to reach a temperature of +15 ºC to +25 ºC before administration.
Shake before use.
Minimum age at vaccination: 8 months.
Administer one dose (2 ml) by deep intramuscular injection in the neck muscles at 5
weeks before the expected parturition date and 3 weeks after the first dose, administer
a second dose.
The basic vaccination scheme is to be repeated prior to each lactation.

None.

- Slight swelling at the injection site of less than 2 cm in diameter, which disappears
within 12 days at most, occurred very commonly during clinical studies.
- Swelling at the injection site higher than 5 cm in diameter, which resolves within 3
days at most, occurred commonly during clinical studies.

Revised: September 2023
Divergence from NI MA following AN: 03684/2022Page 3 of 6- Transient increase in body temperature of up to 1.8 ºC occurred commonly between
the first 4 hours and 3 days after injection during clinical studies, which spontaneously
resolves within some days without compromising animal health status.
- Anaphylactic-type reactions, which might be life-threatening and/or cause abortion
occurred very rarely based on post-authorisation pharmacovigilance reporting. Under
these circumstances, appropriate and rapid symptomatic treatment should be
administered.

- Mild apathy, anorexia and/or recumbency occurred very rarely after administration of
the vaccine based on post-authorisation pharmacovigilance reporting.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).

Vaccinate healthy animals only.
Immunisation has to be considered as one component in a complex mastitis control
programme that addresses all important udder health factors (e.g. milking technique,
dry-off and breeding management, hygiene, nutrition, housing, bedding, animal
comfort, air and water quality, health monitoring) and other management practices.

Special precautions for use in animals
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
To the user:
This veterinary medicinal product contains mineral oil. Accidental injection/self-
injection may result in severe pain and swelling, particularly if injected into a joint or
finger, and in rare cases could result in the loss of the affected finger if prompt medical
attention is not given. If you are accidentally injected with this veterinary medicinal
product, seek prompt medical advice even if only a very small amount is injected and
take the package leaflet with you. If pain persists for more than 12 hours after medical
examination, seek medical advice again.
To the physician:
This veterinary medicinal product contains mineral oil. Even if small amounts have
been injected, accidental injection with this product can cause intense swelling, which
may, for example, result in ischaemic necrosis and even the loss of a digit. Expert,
PROMPT, surgical attention is required and may necessitate early incision and
irrigation of the injected area, especially where there is involvement of finger pulp or
tendon.

No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case by case
basis.

Store and transport refrigerated (2 C - 8 C).
Protect from light.

Revised: September 2023
Divergence from NI MA following AN: 03684/2022Page 5 of 6
Do not freeze.
Once broached use by 10 hours stored at +15 ºC to +25 ºC.

Zero days.
5. IMMUNOLOGICAL PROPERTIES
Pharmacotherapeutic group: Inactivated bacterial vaccines.
ATC vet code: QI03AB.
To stimulate active immunisation against Staphylococcus aureus in ewes.
To stimulate active immunisation against and/or Coagulase-
Negative Staphylococci in female goats.
The full immunisation scheme in goats induces a serological response from 3 weeks
after vaccination. The relevance of these antibody levels to the protection afforded by
the vaccine has not been determined experimentally.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.